Search research articles
Contact Us
Filters
Showing results (41-50 of 171) with videos related to
Page
of 18
Sort By:
Pharmacology & Therapeutics
|
April 8, 2014
Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium
Daniel I Bromage, Sean M Davidson, Derek M Yellon
The International Journal of Biochemistry & Cell Biology
|
April 15, 2008
Molecular regulation of cardiac hypertrophy
Sean P Barry, Sean M Davidson, Paul A Townsend
Basic Research in Cardiology
|
May 26, 2023
The RISK pathway leading to mitochondria and cardioprotection: how everything started
Derek M Yellon, Siavash Beikoghli Kalkhoran, Sean M Davidson
Cardiovascular Drugs and Therapy
|
November 14, 2019
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide
Maryna V Basalay, Sean M Davidson, Derek M Yellon
Neural Regeneration Research
|
April 5, 2020
Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
Maryna V Basalay, Sean M Davidson, Derek M Yellon
Cardiovascular Drugs and Therapy
|
July 6, 2022
Opioids in Acute Coronary Syndromes: Friend or Foe?
Maryna V Basalay, Derek M Yellon, Sean M Davidson
Biochemical Pharmacology
|
September 27, 2008
The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family
Sean M Davidson, Aneta E Rybka, Paul A Townsend
Progress in Molecular and Subcellular Biology
|
March 23, 2002
The developmental expression of small HSP
Sean M Davidson, Marie-Thérèse Loones, Olivier Duverger, et al.
Basic Research in Cardiology
|
June 7, 2025
The contribution of cardiomyocyte hypercontracture to the burden of acute myocardial infarction: an update
Nur Liyana Mohammed Yusof, Derek M Yellon, Sean M Davidson
Journal of Molecular and Cellular Cardiology Plus
|
February 18, 2026
Selective ROCK2 inhibition reduces microvascular obstruction but does not reduce myocardial infarction after ischaemia and reperfusion
Lucie Pearce, David He, Derek M Yellon, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 171) with videos related to
Sort By:
Page
of 18
Pharmacology & Therapeutics
|
April 8, 2014
Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium
Daniel I Bromage, Sean M Davidson, Derek M Yellon
The International Journal of Biochemistry & Cell Biology
|
April 15, 2008
Molecular regulation of cardiac hypertrophy
Sean P Barry, Sean M Davidson, Paul A Townsend
Basic Research in Cardiology
|
May 26, 2023
The RISK pathway leading to mitochondria and cardioprotection: how everything started
Derek M Yellon, Siavash Beikoghli Kalkhoran, Sean M Davidson
Cardiovascular Drugs and Therapy
|
November 14, 2019
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide
Maryna V Basalay, Sean M Davidson, Derek M Yellon
Neural Regeneration Research
|
April 5, 2020
Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
Maryna V Basalay, Sean M Davidson, Derek M Yellon
Cardiovascular Drugs and Therapy
|
July 6, 2022
Opioids in Acute Coronary Syndromes: Friend or Foe?
Maryna V Basalay, Derek M Yellon, Sean M Davidson
Biochemical Pharmacology
|
September 27, 2008
The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family
Sean M Davidson, Aneta E Rybka, Paul A Townsend
Progress in Molecular and Subcellular Biology
|
March 23, 2002
The developmental expression of small HSP
Sean M Davidson, Marie-Thérèse Loones, Olivier Duverger, et al.
Basic Research in Cardiology
|
June 7, 2025
The contribution of cardiomyocyte hypercontracture to the burden of acute myocardial infarction: an update
Nur Liyana Mohammed Yusof, Derek M Yellon, Sean M Davidson
Journal of Molecular and Cellular Cardiology Plus
|
February 18, 2026
Selective ROCK2 inhibition reduces microvascular obstruction but does not reduce myocardial infarction after ischaemia and reperfusion
Lucie Pearce, David He, Derek M Yellon, et al.
Page
of 18